Press Releases
January 2010
SOMAXA PARTNERS WITH 4D BIOMEDICAL
5th January 2010, Somaxa Ltd, a company specialising in medical data solutions for healthcare and pharmaceutical clients, today announced a strategic partnership with 4D Biomedical Ltd, a specialist consultancy with expertise in translational medicine.
The Somaxa / 4D partnership brings together the skills of each consultancy organisation to help address challenges facing the life science industry, with a particular interest in the generation of value from electronic medical data for patients, healthcare professionals and pharmaceutical research and development (R&D).
“We are delighted to be able to partner with 4D Biomedical. 4D is renowned for the creation of translational medicine hubs that harness academic excellence, medical expertise and industry application. We are excited to be able to contribute the expertise of Somaxa to support 4D’s future work in what is proving to be an exciting field.” said Dr Julie Barnes, founding Director of Somaxa.
George Freeman, 4D’s Consulting Director, said “Somaxa are unique in having a real depth of understanding of the life science technology that can be applied to healthcare data as well as an understanding of its potential application for R&D. This will be of tremendous value to our clients.”
Notes to Editors
ABOUT SOMAXA LTD
With over 30 years combined experience in pharmaceutical research and development, Somaxa works with medical data and technology partners to deliver solutions to business problems for healthcare and pharmaceutical research and development.
ABOUT 4D BIOMEDICAL LTD
4D Biomedical is a consultancy business specialising in helping to develop and commercialise new biomedical technologies. The 4D Biomedical team advised on the ground breaking $50m biomarker collaboration between the NHS, four UK universities and Wyeth Pharmaceuticals announced in April 2006.